Top experts by indication / Oncology
Most active experts in Pancreatic Cancer
2026 edition, data as of October 26, 2026
561 key opinion leaders in the directory are tagged to Pancreatic Cancer. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 284 of the 561 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Andrew KoCA | 13 trials |
| 2 | Dung LeJohns Hopkins University School of Medicine, MD | 11 trials |
| 3 | Daniel LaheruJohns Hopkins University School of Medicine, MD | 10 trials |
| 4 | Mark ZalupskiUniversity of Michigan, MI | 10 trials |
| 5 | Andrew HendifarCedars-Sinai Medical Center, CA | 10 trials |
| 6 | Michael PishvaianJohns Hopkins University School of Medicine, DC | 10 trials |
| 7 | Nilofer AzadJohns Hopkins University School of Medicine, MD | 9 trials |
| 8 | Hedy KindlerUniversity of Chicago, IL | 9 trials |
| 9 | Erkut BorazanciHonorHealth Research Institute, AZ | 8 trials |
| 10 | Ramesh RamanathanAZ | 7 trials |
| 11 | Howard SafranBrown University, RI | 7 trials |
| 12 | Peter O'DwyerECOG-ACRIN Cancer Research Group, PA | 6 trials |
| 13 | Milind JavleThe University of Texas MD Anderson Cancer Center, TX | 6 trials |
| 14 | Edward KimCity of Hope, CA | 6 trials |
| 15 | Wells MessersmithUniversity of Colorado Cancer Center, CO | 6 trials |
| 16 | Alexander SpiraVirginia Cancer Specialists, VA | 5 trials |
| 17 | Brandon SmagloHouston Methodist, TX | 5 trials |
| 18 | Matthew KatzNH | 5 trials |
| 19 | Amol NarangJohns Hopkins University School of Medicine, MD | 5 trials |
| 20 | Renuka IyerRoswell Park Comprehensive Cancer Center, NY | 5 trials |
| 21 | Olatunji AleseEmory University, GA | 5 trials |
| 22 | Albert KoongThe University of Texas MD Anderson Cancer Center, TX | 5 trials |
| 23 | Udo RudloffMD | 4 trials |
| 24 | Herbert ZehHarold C. Simmons Comprehensive Cancer Center, PA | 4 trials |
| 25 | Steven CohenPA | 4 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 91 of the 561 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Charles FuchsTubulis GmbH | 114,486 citations |
| 2 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 3 | Al BensonNorthwestern University Feinberg School of Medicine, IL | 74,238 citations |
| 4 | Howard BurrisSarah Cannon Research Institute, TN | 72,593 citations |
| 5 | Mitesh BoradMayo Clinic, AZ | 60,996 citations |
| 6 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 59,091 citations |
| 7 | Geoffrey ShapiroDana-Farber Cancer Institute, MA | 58,071 citations |
| 8 | Edward GaronUniversity of California, Los Angeles, CA | 56,135 citations |
| 9 | Tim GretenNational Institutes of Health, MD | 54,882 citations |
| 10 | Dung LeJohns Hopkins University School of Medicine, MD | 49,697 citations |
| 11 | Ravi SalgiaCity of Hope, CA | 48,747 citations |
| 12 | David HongThe University of Texas MD Anderson Cancer Center, TX | 47,734 citations |
| 13 | Robert VonderheideUniversity of Pennsylvania, PA | 45,666 citations |
| 14 | Herbert ZehHarold C. Simmons Comprehensive Cancer Center, PA | 43,713 citations |
| 15 | Peter O'DwyerECOG-ACRIN Cancer Research Group, PA | 43,318 citations |
| 16 | Jordan BerlinVanderbilt University Medical Center, TN | 40,633 citations |
| 17 | Hedy KindlerUniversity of Chicago, IL | 39,455 citations |
| 18 | Daniel LaheruJohns Hopkins University School of Medicine, MD | 36,734 citations |
| 19 | Jennifer TemelMassachusetts General Hospital, MA | 36,476 citations |
| 20 | Patricia LorussoYale School of Medicine, MI | 34,992 citations |
| 21 | Neal MeropolFlatiron Health, NY | 32,657 citations |
| 22 | Vivek SubbiahStanford University School of Medicine, CA | 32,217 citations |
| 23 | Michael OvermanThe University of Texas MD Anderson Cancer Center, TX | 32,085 citations |
| 24 | Jeffrey InfanteTN | 31,614 citations |
| 25 | Brian WolpinDana-Farber Cancer Institute, MA | 30,999 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 67 of the 561 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Peter O'DwyerECOG-ACRIN Cancer Research Group, PA | 15 awards |
| 2 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 13 awards |
| 3 | Geoffrey ShapiroDana-Farber Cancer Institute, MA | 11 awards |
| 4 | William GillandersMO | 10 awards |
| 5 | Jennifer TemelMassachusetts General Hospital, MA | 10 awards |
| 6 | Sunil KrishnanMemorial Hermann, TX | 9 awards |
| 7 | Robert VonderheideUniversity of Pennsylvania, PA | 9 awards |
| 8 | Al BensonNorthwestern University Feinberg School of Medicine, IL | 8 awards |
| 9 | Jordan BerlinVanderbilt University Medical Center, TN | 8 awards |
| 10 | Charles ErlichmanMN | 7 awards |
| 11 | Anthony ShieldsMI | 6 awards |
| 12 | Hedy KindlerUniversity of Chicago, IL | 6 awards |
| 13 | Steven AlbertsMayo Clinic, MN | 6 awards |
| 14 | Charles FuchsTubulis GmbH | 5 awards |
| 15 | Bryan AllenIA | 5 awards |
| 16 | Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA | 5 awards |
| 17 | Nilofer AzadJohns Hopkins University School of Medicine, MD | 5 awards |
| 18 | Patrick LoehrerIndiana University School of Medicine, IN | 5 awards |
| 19 | Jill LacyYale School of Medicine, CT | 4 awards |
| 20 | David HongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 21 | Mark ZalupskiUniversity of Michigan, MI | 4 awards |
| 22 | Wells MessersmithUniversity of Colorado Cancer Center, CO | 4 awards |
| 23 | Edward GaronUniversity of California, Los Angeles, CA | 4 awards |
| 24 | Albert KoongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 25 | Patricia LorussoYale School of Medicine, MI | 4 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 38 of the 561 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Erika HamiltonSarah Cannon Research Institute, TN | 364 contributions |
| 2 | Michael OvermanThe University of Texas MD Anderson Cancer Center, TX | 333 contributions |
| 3 | Johanna BendellPfizer, TN | 310 contributions |
| 4 | Geoffrey ShapiroDana-Farber Cancer Institute, MA | 277 contributions |
| 5 | Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA | 275 contributions |
| 6 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 7 | Theodore HongMassachusetts General Hospital, MA | 250 contributions |
| 8 | Siqing FuThe University of Texas MD Anderson Cancer Center, TX | 241 contributions |
| 9 | Cathy EngVanderbilt University Medical Center, TN | 240 contributions |
| 10 | Zev WainbergUniversity of California, Los Angeles, CA | 233 contributions |
| 11 | Anthony TolcherNEXT Oncology, TX | 229 contributions |
| 12 | Milind JavleThe University of Texas MD Anderson Cancer Center, TX | 228 contributions |
| 13 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 14 | Albert KoongThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 15 | Jennifer TemelMassachusetts General Hospital, MA | 202 contributions |
| 16 | Andrew HendifarCedars-Sinai Medical Center, CA | 182 contributions |
| 17 | Michael PishvaianJohns Hopkins University School of Medicine, DC | 165 contributions |
| 18 | Hedy KindlerUniversity of Chicago, IL | 163 contributions |
| 19 | Al BensonNorthwestern University Feinberg School of Medicine, IL | 160 contributions |
| 20 | Jordan BerlinVanderbilt University Medical Center, TN | 156 contributions |
| 21 | Elena ChioreanUniversity of Washington, WA | 154 contributions |
| 22 | Davendra SohalUniversity of Cincinnati, OH | 144 contributions |
| 23 | Richard KimMoffitt Cancer Center, FL | 141 contributions |
| 24 | Steven AlbertsMayo Clinic, MN | 138 contributions |
| 25 | Anwaar SaeedUniversity of Pittsburgh, KS | 123 contributions |
Emerging
41 of the 561 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Abdullah AbbasiUniversity of Iowa, IA |
| Olivia AranhaWashington University School of Medicine in St. Louis, MO |
| Fares AyoubBaylor College of Medicine, TX |
| Fiyinfolu BalogunMemorial Sloan Kettering Cancer Center, NY |
| Marina BarettiJohns Hopkins University School of Medicine, MD |
| Gregory BeattyUniversity of Pennsylvania, PA |
| Cathy EngVanderbilt University Medical Center, TN |
| Cristina FerroneCedars-Sinai Medical Center, CA |
| Hans GerdesMemorial Sloan Kettering Cancer Center, NY |
| Nima GhalehsariMoffitt Cancer Center, FL |
| Patrick GriersonWashington University School of Medicine in St. Louis, MO |
| Brett HerzogIL |
| Sunil HingoraniFred Hutchinson Cancer Center, WA |
| Spiros HiotisIcahn School of Medicine at Mount Sinai, NY |
| Theodore HongMassachusetts General Hospital, MA |
| Courtney HouchenOklahoma City VA Medical Center, OK |
| Brian KaderaUniversity of California, Los Angeles, CA |
| Udai KammulaUniversity of Pittsburgh, PA |
| Samir KhleifGeorgetown University School of Medicine, GA |
| Abdallah KobeissyUniversity of Toledo, OH |
| Jeremy KratzWI |
| Theodore LawrenceUniversity of Michigan, MI |
| Heinz-Josef LenzUSC Norris Comprehensive Cancer Center, CA |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Daniel NussbaumNC |
How these tables are computed
The cohort is every profile in the directory tagged to Pancreatic Cancer, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Pancreatic Cancer profile in the directory